药局的市场:现状分析与预测(2022-2028年)

药房是向患者配发和销售药品、药品和其他保健品的场所。我们还可能提供有关药物使用的建议和信息，并提供其他与健康相关的产品和服务。此外，由于慢性病的流行和对仿製药的需求不断增长，药品市场预计将扩大。根据美国食品和药物管理局的数据，到 2022 年，美国大约 90% 的处方药（即十分之九）将是非专利药。因此，改善医疗服务将使更多的人能够使用药房服务。

为了更好地了解製药行业的市场采用情况，市场分为北美（美国、加拿大、北美其他地区）、欧洲（德国、英国、法国、意大利、西班牙、欧洲其他地区）、亚太地区（中国、日本、印度、亚太其他地区）以及基于其他地区国家的全球影响力的分析。2021 年的药品市场由北美主导，因为该地区人口众多且多样化，导致药品和服务需求激增。此外，由于人口老龄化，对药品和医疗保健服务的需求不断增加。据美国人口普查局统计，美国有超过5600万65岁及以上的成年人居住，到2021年，他们将占美国人口的16.9%左右。此外，该地区拥有完善的医疗保健系统，包括众多医院和诊所以及众多药房。

目录

第1章 市场简介

• 市场定义
• 主要目的
• 相关利益者
• 限制事项

第2章 调查手法或前提

• 调查流程
• 调查手法
• 受访者简介

第3章 市场摘要

第4章 摘要整理

第5章 全球药局市场，新型冠状病毒感染疾病(COVID-19)的影响

第6章 全球药局的市场收益，2020-2028年

第7章 市场洞察:各产品类型

• 处方
• 店面销售(OTC)

第8章 市场洞察:药局各类型

• 医院药局
• 零售业的药局
• 网路药局
• 其他

第9章 市场洞察:各地区

• 北美的药局市场
  • 美国
  • 加拿大
  • 其他北美地区
• 欧洲的药局市场
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 其他欧洲地区
• 亚太地区的药局市场
  • 中国
  • 日本
  • 印度
  • APAC的其他各国
• 其他地区的药局市场

第10章 药局的市场动态

• 推动市场要素
• 市场课题
• 影响分析

第11章 药局的市场机会

第12章 药局的市场趋势

第13章 需求面和供给面的分析

• 需求面分析
• 供给面分析

第14章 价值链分析

第15章 价格分析

第16章 策略性洞察能力

第17章 竞争模式

• 竞争情形
  • 波特的五力分析

第18章 企业简介

• Pfizer Inc.
• Johnson & Johnson Services, Inc.
• CVS Health
• Novartis AG
• Sanofi
• Merck & Co., Inc.
• GSK plc.
• AstraZeneca
• AbbVie Inc.
• F. Hoffmann-La Roche Ltd

第19章 免责声明

A pharmacy is a place where drugs, medicines, and other healthcare products are dispensed and sold to patients. It can provide advice and information on medication use, as well as other health-related products and services. In addition, the increasing prevalence of chronic diseases and the rising demand for generic medicines are expected to grow the pharmacy market. According to the U.S. Food & Drug Administration, in 2022, approx 90% of all prescriptions in the United States i.e. about 9 out of 10 are generics. Therefore, increasing access to healthcare can help more people access the services which are provided by pharmacies.

The Pharmacy Market is expected to grow at a strong CAGR of 4.5% during the forecast period owing to the growing technological advancements in the pharmacy sector such as telemedicine and online pharmacies. Moreover, the key players have rapidly adopted strategic alliances such as collaboration, product launches, and joint ventures, to maintain a competitive edge in the global market. For instance, in September 2022, RxDefine announced the introduction of RxTelehealth, its telehealth solution for life sciences brands.

Based on product type, the pharmacy market is bifurcated into prescription, and over the counter (OTC). The prescription segment held a significant share of the market in 2021 with the highest market share. This is mainly attributed to the increasing demand for medical products and services, such as healthcare products, pharmaceuticals, and medical devices along with the rise in chronic diseases and an aging population that will drain pharmaceutical products high as more people need regular medications. The World Health Organization stated that around 41 million people die from non-communicable diseases (NCDs) each year, equivalent to 74% of all deaths globally in 2022.

By pharmacy type, the market is segmented into hospital pharmacy, retail pharmacy, epharmacy, and others. Among these, hospital pharmacy is expected to grow with a significant CAGR during the forecast period. This is mainly due to the hospital pharmacies adopting technologies to improve patient safety and health outcomes by providing some patients access to the right medications, in the right amounts and at the right time.

For a better understanding of the market adoption of the Pharmacy industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, U.K., France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), Rest of World. North America dominated the pharmacy market in 2021 due to the presence of a significant and diverse population in the region establishing a surge in demand for pharmaceutical products and services. In addition, the increasing geriatric population leads to an increased demand for medications and healthcare services. According to the U.S. Census Bureau, above 56 million adults ages 65 and older live in the United States, accounting for about 16.9% of the nation's population in 2021. Moreover, the region has a well-established healthcare system that includes a large number of hospitals and clinics, as well as a large number of pharmacies.

Some of the major players operating in the market include: Pfizer Inc.; Johnson & Johnson Services, Inc.; CVS Health; Novartis AG; Sanofi; GSK plc.; AstraZeneca; AbbVie Inc; F. Hoffmann-La Roche Ltd.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

• 1.1. Market Definitions
• 1.2. Main Objective
• 1.3. Stakeholders
• 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1. Research Process of the Pharmacy Market
• 2.2. Research Methodology of the Pharmacy Market
• 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL PHARMACY MARKET COVID-19 IMPACT

6 GLOBAL PHARMACY MARKET REVENUE, 2020-2028F

7 MARKET INSIGHTS BY PRODUCT TYPE

• 7.1. Prescription
• 7.2. Over the Counter (OTC)

8 MARKET INSIGHTS BY PHARMACY TYPE

• 8.1. Hospital Pharmacy
• 8.2. Retail Pharmacy
• 8.3. ePharmacy
• 8.4. Others

9 MARKET INSIGHTS BY REGION

• 9.1. North America Pharmacy Market
  • 9.1.1. U.S.
  • 9.1.2. Canada
  • 9.1.3. Rest of North America
• 9.2. Europe Pharmacy Market
  • 9.2.1. Germany
  • 9.2.2. U.K.
  • 9.2.3. France
  • 9.2.4. Italy
  • 9.2.5. Spain
  • 9.2.6. Rest of Europe
• 9.3. Asia-Pacific Pharmacy Market
  • 9.3.1. China
  • 9.3.2. Japan
  • 9.3.3. India
  • 9.3.4. Rest of APAC
• 9.4. Rest of the World Pharmacy Market

10 PHARMACY MARKET DYNAMICS

• 10.1. Market Drivers
• 10.2. Market Challenges
• 10.3. Impact Analysis

11 PHARMACY MARKET OPPORTUNITIES

12 PHARMACY MARKET TRENDS

13 DEMAND AND SUPPLY-SIDE ANALYSIS

• 13.1. Demand Side Analysis
• 13.2. Supply Side Analysis

14 VALUE CHAIN ANALYSIS

15 PRICING ANALYSIS

16 STRATEGIC INSIGHTS

17 COMPETITIVE SCENARIO

• 17.1. Competitive Landscape
  • 17.1.1. Porters Fiver Forces Analysis

18 COMPANY PROFILED

• 18.1. Pfizer Inc.
• 18.2. Johnson & Johnson Services, Inc.
• 18.3. CVS Health
• 18.4. Novartis AG
• 18.5. Sanofi
• 18.6. Merck & Co., Inc.
• 18.7. GSK plc.
• 18.8. AstraZeneca
• 18.9. AbbVie Inc.
• 18.10. F. Hoffmann-La Roche Ltd

19 DISCLAIMER